Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults (Q113939186)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults |
clinical trial |
Statements
ENLIGHTEN 1 (English)
0 references
ENLIGHTEN 1: A Phase III, Randomized, Blinded, Controlled, Parallel-Group Trial to Evaluate the Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis (CRS) in Adults (English)
0 references
27 January 2022
0 references
31 August 2023
0 references
180
0 references
18 year
0 references